- Home
- MAZE vs NXXT Comparison
MAZE vs NXXT Comparison
Compare MAZE & NXXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAZE
- NXXT
- Stock Information
- Founded
- MAZE 2018
- NXXT 2019
- Country
- MAZE United States
- NXXT United States
- Employees
- MAZE N/A
- NXXT N/A
- Industry
- MAZE
- NXXT
- Sector
- MAZE
- NXXT
- Exchange
- MAZE NYSE
- NXXT NYSE
- Market Cap
- MAZE 367.0M
- NXXT 390.9M
- IPO Year
- MAZE 2025
- NXXT N/A
- Fundamental
- Price
- MAZE $9.86
- NXXT $3.06
- Analyst Decision
- MAZE Strong Buy
- NXXT
- Analyst Count
- MAZE 3
- NXXT 0
- Target Price
- MAZE $25.67
- NXXT N/A
- AVG Volume (30 Days)
- MAZE 199.0K
- NXXT 47.9K
- Earning Date
- MAZE 01-01-0001
- NXXT 05-23-2025
- Dividend Yield
- MAZE N/A
- NXXT N/A
- EPS Growth
- MAZE N/A
- NXXT N/A
- EPS
- MAZE 1.25
- NXXT N/A
- Revenue
- MAZE $167,500,000.00
- NXXT $27,770,279.00
- Revenue This Year
- MAZE N/A
- NXXT N/A
- Revenue Next Year
- MAZE N/A
- NXXT N/A
- P/E Ratio
- MAZE $7.86
- NXXT N/A
- Revenue Growth
- MAZE N/A
- NXXT 19.61
- 52 Week Low
- MAZE $6.71
- NXXT $2.19
- 52 Week High
- MAZE $17.00
- NXXT $7.55
- Technical
- Relative Strength Index (RSI)
- MAZE N/A
- NXXT N/A
- Support Level
- MAZE N/A
- NXXT N/A
- Resistance Level
- MAZE N/A
- NXXT N/A
- Average True Range (ATR)
- MAZE 0.00
- NXXT 0.00
- MACD
- MAZE 0.00
- NXXT 0.00
- Stochastic Oscillator
- MAZE 0.00
- NXXT 0.00
About MAZE MAZE THERAPEUTICS INC
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
About NXXT NEXTNRG INC
NextNRG Inc is engaged in developing an integrated ecosystem that combines solar energy generation, battery storage, smart microgrids, wireless electric vehicle (EV) charging, and on-demand fuel delivery. The company is also focused on combining renewable energy innovation with mobile fueling expertise to build a sustainable energy ecosystem that bridges traditional fuel needs with AI-powered clean energy solutions.